Naphthalene ring-containing compound, pharmaceutical composition containing same, and use thereof
AssigneesJiangsu Yahong Meditech Co., Ltd., Asieris Pharmaceuticals (Shanghai) Co., Ltd.
InventorsLiang WU, Yijun DENG, Zhenhua HE, Qiaoling SUN, Chen ZHOU, Tielin WANG
Life of this patent
Estimating the term…
Abstract
Anaphthalene ring-containing compound, a pharmaceutical composition containing same, and the use thereof. A naphthalene ring-containing compound as represented by formula III, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of the pharmaceutically acceptable salt thereof. The compound is new in structure and has a better activity on cancers.
Claims20
A naphthalene ring-containing compound of formula III, a pharmaceutically acceptable salt thereof, a solvate thereof, or a solvate of the pharmaceutically acceptable salt thereof,
- wherein R1 is hydrogen, cyano, hydroxyl, or C1-C4 alkoxy;
- X1 is —O—, 5- to 6-membered heterocycloalkylene, or 5- to 6-membered heterocycloalkylene substituted by Rx1-1;
- in the 5- to 6-membered heterocycloalkylene and the 5- to 6-membered heterocycloalkylene substituted by Rx1-1, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, or 3;
- Rx1-1 is independently C1-C4 alkyl;
- X2 is absent, —C(═O)—, C1-C6 alkylene, C2-C15 heteroalkylene, or C2-C15 heteroalkylene substituted by R21;
- in the C2-C15 heteroalkylene, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, 3, 4, 5, 6, 7, 8, or 9;
- Rx2-1 is independently C1-C4 alkyl;
- X3 is absent, —C(═O)-Ph-, 5- to 6-membered heterocycloalkylene, 5- to 6-membered heteroarylene, 5- to 6-membered heterocycloalkylene substituted by Rx31, or 5- to 6-membered heteroarylene substituted by Rx3-2;
- in the 5- to 6-membered heterocycloalkylene and the 5- to 6-membered heterocycloalkylene substituted by Rx3-1, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, or 3;
- in the 5- to 6-membered heteroarylene and the 5- to 6-membered heteroarylene substituted by Rx3-2, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, or 3;
- Rx3-1 and Rx3-2 are independently C1-C4 alkyl;
- X4 is absent, C1-C10 alkylene, or C2-C15 heteroalkylene;
- in the C2-C15 heteroalkylene, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, 3, 4, 5, 6, 7, 8, or 9;
- X5 is absent, 5- to 6-membered heterocycloalkylene, or 5- to 6-membered heterocycloalkylene substituted by Rx5-1;
- in the 5- to 6-membered heterocycloalkylene and the 5- to 6-membered heterocycloalkylene substituted by Rx5-1, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, or 3;
- Rx5-1 is independently C1-C4 alkyl;
- X6 is absent, —O—, —NH—, —C(═O)—NH—, 5- to 6-membered heterocycloalkylene, —C(═O)-5- to 6-membered heterocycloalkylene, or 5- to 6-membered heterocycloalkylene substituted by Rx6-1;
- in the 5- to 6-membered heterocycloalkylene, the —C(═O)-5- to 6-membered heterocycloalkylene, and the 5- to 6-membered heterocycloalkylene substituted by Rx6-1, the heteroatom is one or more than one of O, S, and N, and the number of heteroatoms is 1, 2, or 3;
- Rx6-1 is independently C1-C4 alkyl;
- R2 is
- R4 is —SO2—C1-C4 alkyl or
- R3 is
- or 3- to 6-membered heterocycloalkyl, Ra and Rb are independently hydrogen or C1-C4 alkyl;
- in the 3- to 6-membered heterocycloalkyl, the heteroatom is N, and the number of heteroatoms is 1 or 2.
A compound or a salt thereof, which has any one of the following structures:
Dependencies are inferred from the claim text.